{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:34:42Z","timestamp":1761510882175},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00101-005-0919-x","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T12:06:29Z","timestamp":1128600389000},"page":"1047-1066","source":"Crossref","is-referenced-by-count":7,"title":["Diagnostik und Therapie invasiver Pilzinfektionen auf der Intensivstation"],"prefix":"10.1007","volume":"54","author":[{"given":"S.","family":"Koch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Haefner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Huenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Haase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wildberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. W.","family":"Lemmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"919_CR1","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00108-003-1065-7","volume":"44","author":"Battegay","year":"2003","unstructured":"Battegay M, Fl\u00fcckiger U (2003) Therapie schwerer Pilzinfektionen. Internist 44:1549\u20131556","journal-title":"Internist"},{"key":"919_CR2","doi-asserted-by":"crossref","unstructured":"B\u00f6hme A, Ruhnke M, Buchheidt D et al. (2003) Treatment of fungal infections in hematology and oncology-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82 [Suppl 2]:133\u2013140","DOI":"10.1007\/s00277-003-0767-1"},{"key":"919_CR3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1086\/513943","volume":"26","author":"Denning","year":"1998","unstructured":"Denning DW (1998) Invasive aspergillosis. Clin Infect Dis 26:781\u2013803","journal-title":"Clin Infect Dis"},{"key":"919_CR4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/CDLI.10.5.882-885.2003","volume":"10","author":"Digby","year":"2003","unstructured":"Digby J, Kalbfleisch J, Glenn A et al. (2003) Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10:882\u2013885","journal-title":"Clin Diagn Lab Immunol"},{"key":"919_CR5","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1086\/429722","volume":"40","author":"Drew","year":"2005","unstructured":"Drew RH, Arthur RR, Perfect JR (2005) Is it time to abandon the use of Amphotericin B bladder irrigation? Clin Infect Dis 40:1465\u20131470","journal-title":"Clin Infect Dis"},{"key":"919_CR6","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00003246-199906000-00019","volume":"27","author":"Eggimann","year":"1999","unstructured":"Eggimann P, Francioli P, Bille J et al. (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27:1066\u20131072","journal-title":"Crit Care Med"},{"key":"919_CR7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/CMR.9.4.499","volume":"9","author":"Fridkin","year":"1996","unstructured":"Fridkin SK, Jarvis WR (1996) Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 9:499\u2013511","journal-title":"Clin Microbiol Rev"},{"key":"919_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2004-815713","volume":"39","author":"Geffers","year":"2004","unstructured":"Geffers C, Zuschneid I, Sohr D et al. (2004) Microbiological isolates associated with nosocomial infections in intensive care units: data of 274 intensive care units participating in the German Nosocomial Infections Surveillance System (KISS). Anasthesiol Intensivmed Notfallmed Schmerzther 39:15\u201319","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"919_CR9","unstructured":"Haase G, Borg-von Zepelin M, Bernhardt H et al. (2001) Qualit\u00e4tsstandards in der mikrobiologischen Diagnostik. Pilzinfektionen Teil I Pr\u00e4analytik, Analytik (MiQ 14), Pilzinfektionen Teil II Spezielle Pilzdiagnostik (MiQ 15). Urban & Fischer, M\u00fcnchen Jena"},{"key":"919_CR10","unstructured":"Henderson HM, Chapman SW (2003) Infections due to fungi, Actinomyces and Norcardia. In: Betts RF, Chapman SW, Penn RL (eds) Reese and betts: a practical approach to infectious diseases. Williams Wilkens, Lippincott Philadelphia, pp 558\u2013648"},{"key":"919_CR11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF et al. (2002) Voriconazole vs. amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408\u2013415","journal-title":"N Engl J Med"},{"key":"919_CR12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ehj.2003.11.008","volume":"25","author":"Horstkotte","year":"2004","unstructured":"Horstkotte D, Follath F, Gutschik E et al. (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 25:267\u2013276","journal-title":"Eur Heart J"},{"key":"919_CR13","doi-asserted-by":"crossref","unstructured":"Link H, B\u00f6hme A, Cornely OA et al. (2003) Antimicrobial therapy of unexplained fever in neutropenic patients-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 82 [Suppl 2]:105\u2013117","DOI":"10.1007\/s00277-003-0764-4"},{"key":"919_CR14","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/423381","volume":"39","author":"Maertens","year":"2004","unstructured":"Maertens J, Raad I, Petrikkos G et al. (2004) Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 39:1563\u20131571","journal-title":"Clin Infect Dis"},{"key":"919_CR15","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s001030050283","volume":"42","author":"Martius","year":"1999","unstructured":"Martius J, Br\u00fchl P, Dettenkofer M et al. (1999) Empfehlungen zur Pr\u00e4vention und Kontrolle Katheter-assoziierter Harnwegsinfektionen, Mitteilungen der Kommission f\u00fcr Krankenhaushygiene und Infektionspr\u00e4vention am Robert Koch-Institut. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 42:806\u2013809","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"919_CR16","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00108-002-0713-7","volume":"43","author":"Maschmeyer","year":"2002","unstructured":"Maschmeyer G, Ruhnke M (2002) Arzneimitteltherapie invasiver Candida- und Aspergillusinfektionen. Internist 43:1464\u20131476","journal-title":"Internist"},{"key":"919_CR17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1439-0507.2004.01003.x","volume":"47","author":"Maschmeyer","year":"2004","unstructured":"Maschmeyer G, Ruhnke M (2004) Update on antifungal treatment of invasive Candida and Aspergillus infections. Mycoses 47:263\u2013276","journal-title":"Mycoses"},{"key":"919_CR18","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","volume":"347","author":"Mora-Duarte","year":"2002","unstructured":"Mora-Duarte J, Betts R, Rotstein C et al. (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347:2020\u20132029","journal-title":"N Engl J Med"},{"key":"919_CR19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0924-8579(00)00147-3","volume":"15","author":"Munoz","year":"2000","unstructured":"Munoz P, Burillo A, Bouza E (2000) Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. Int J Antimicrob Agents 15:83\u201390","journal-title":"Int J Antimicrob Agents"},{"key":"919_CR20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","volume":"38","author":"Pappas","year":"2004","unstructured":"Pappas PG, Rex JH, Sobel JD et al. (2004) IDSA Guidelines for Treatment of Candidiasis. http:\/\/www.journals.uchicago.edu\/CID\/journal\/issues\/v38n2\/32301\/32301.text.html-fn1#fn1. Clin Infect Dis 38:161\u2013189","journal-title":"Clin Infect Dis"},{"key":"919_CR21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00000658-200104000-00010","volume":"233","author":"Pelz","year":"2001","unstructured":"Pelz RK, Hendrix CW, Swoboda SM et al. (2001) Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 233:542\u2013548","journal-title":"Ann Surg"},{"key":"919_CR22","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","volume":"331","author":"Rex","year":"1994","unstructured":"Rex JH, Bennett JE, Sugar AM et al. (1994) A randomized trial comparing Fluconazole with Amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331:1325\u20131330","journal-title":"N Engl J Med"},{"key":"919_CR23","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1086\/318517","volume":"32","author":"Rex","year":"2001","unstructured":"Rex JH, Sobel JD (2001) Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 32:1191\u20132000","journal-title":"Clin Infect Dis"},{"key":"919_CR24","first-page":"72","volume":"2","author":"Rimek","year":"2005","unstructured":"Rimek D (2005) Wertigkeit des Aspergillus-Galaktomannan-Antigen-Nachweises zur Diagnostik invasiver Aspergillosen. Mikrobiologe 2:72","journal-title":"Mikrobiologe"},{"key":"919_CR25","doi-asserted-by":"crossref","unstructured":"Ruhnke M (2004) Mykosen. In: Adam D, Doerr HW, Link H, Lode H (Hrsg) Die Infektiologie. Springer, Berlin Heidelberg New York Tokyo, S 1131\u20131146","DOI":"10.1007\/978-3-642-18577-9_30"},{"key":"919_CR26","first-page":"360","volume":"12","author":"Ruhnke","year":"2004","unstructured":"Ruhnke M, Rosseau S, Graf B (2004) Invasive Pilzinfektionen auf der Intensivstation. Arzneimitteltherapie 12:360\u2013370","journal-title":"Arzneimitteltherapie"},{"key":"919_CR27","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/313756","volume":"30","author":"Stevens","year":"2000","unstructured":"Stevens DA, Kan VL, Judson MA et al. (2000) Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 30:696\u2013709","journal-title":"Clin Infect Dis"},{"key":"919_CR28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.1995.03530080055041","volume":"274","author":"Vincent","year":"1995","unstructured":"Vincent JL, Bihari DJ, Suter PM et al. (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639\u2013644","journal-title":"JAMA"},{"key":"919_CR29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1086\/338715","volume":"34","author":"Walsh","year":"2002","unstructured":"Walsh TJ, Rex JH (2002) All catheter-related candidemia is not the same: assessment of the balance between the risks and benefits of removal of vascular catheters. Clin Infect Dis 34:600\u2013602","journal-title":"Clin Infect Dis"},{"key":"919_CR30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"Wisplinghoff","year":"2004","unstructured":"Wisplinghoff H, Bischoff T, Tallent SM et al. (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309\u2013317","journal-title":"Clin Infect Dis"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-005-0919-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-005-0919-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-005-0919-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T05:04:41Z","timestamp":1586495081000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-005-0919-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["919"],"URL":"https:\/\/doi.org\/10.1007\/s00101-005-0919-x","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}